Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom; School of Environment and Life Sciences, University of Salford, Salford, United Kingdom; and Department of Physiology, VU University Medical Centre, Amsterdam, Netherlands.
Physiol Rev. 2019 Oct 1;99(4):1701-1763. doi: 10.1152/physrev.00034.2018.
Obesity is increasingly prevalent and is associated with substantial cardiovascular risk. Adipose tissue distribution and morphology play a key role in determining the degree of adverse effects, and a key factor in the disease process appears to be the inflammatory cell population in adipose tissue. Healthy adipose tissue secretes a number of vasoactive adipokines and anti-inflammatory cytokines, and changes to this secretory profile will contribute to pathogenesis in obesity. In this review, we discuss the links between adipokine dysregulation and the development of hypertension and diabetes and explore the potential for manipulating adipose tissue morphology and its immune cell population to improve cardiovascular health in obesity.
肥胖症越来越普遍,与大量心血管风险相关。脂肪组织的分布和形态在决定不良影响的程度方面起着关键作用,而在疾病过程中的一个关键因素似乎是脂肪组织中的炎症细胞群体。健康的脂肪组织会分泌许多血管活性脂肪因子和抗炎细胞因子,这种分泌谱的变化将有助于肥胖症的发病机制。在这篇综述中,我们讨论了脂肪因子失调与高血压和糖尿病的发展之间的联系,并探讨了操纵脂肪组织形态及其免疫细胞群体以改善肥胖症患者心血管健康的可能性。